Literature DB >> 667792

Serum clearance rates of immunologically reactive thyroglobulin.

P L Gerfo, T Colacchio, D Colacchio, C Feind.   

Abstract

Serum thyroglobulin levels have been shown to have a role in detecting the presence of residual or recurrent disease in most patients who have undergone total thyroidectomy for thyroid cancer. It has not yet been determined at what interval postoperatively to begin following serum thyroglobulin levels in these patients to detect residual disease. Eight patients who underwent total thyroidectomy were studied to determine the clearance rate of this glycoproteint. Serial samples were obtained pre- and postoperatively and clearance rate curves were plotted for each patient. The average half-life of thyroglobulin was 14 hours, with a range of 8 to 22 hours. Based upon these results, it appears that 4 weeks is a sufficient period of time to allow for the clearance of the residual thyroglobulin in patients undergoing total thyroidectomy. Elevated levels of serum thyroglobulin after this time represent residual thyroid tissue or the presence of metastatic thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667792     DOI: 10.1002/1097-0142(197807)42:1<164::aid-cncr2820420127>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.

Authors:  N Lima; H Cavaliere; E Tomimori; M Knobel; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

4.  Lymphocyte blastogenic response to human thyroglobulin in Graves' disease, Hashimoto's thyroiditis, and metastatic thyroid cancer.

Authors:  N Aoki; J DeGroot
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

5.  Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter.

Authors:  U Feldt-Rasmussen; P H Petersen; J Date; C M Madsen
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

6.  BEHAVIOUR OF EARLY THYROGLOBULIN AFTER TOTAL THYROIDECTOMY FOR DIFFERENTIATED THYROID CANCER.

Authors:  D Pérez; M Marulanda; A Sanabria
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

7.  Serum Thyroglobulin: Preoperative Levels and Factors Affecting Postoperative Optimal Timing following Total Thyroidectomy.

Authors:  Anery Patel; Valerie Shostrom; Kelly Treude; William Lydiatt; Russell Smith; Whitney Goldner
Journal:  Int J Endocrinol       Date:  2019-02-20       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.